Exploring the Role of RGD-Recognizing Integrins in CancerMarkus Nieberler(TUM Klinikum), Horst Kessler(Institute for Advanced Study)CancersSeptember 4, 201710.3390/cancers9090116Cited by 438SaveCiteExport RISWatch citationsRelated PapersA Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins|Scientific Reports|2017|597<sup>31</sup>P‐CP–MAS NMR studies on TPP<sup>+</sup> bound to the ion‐coupled multidrug transport protein EmrE|FEBS Letters|2000|28